Cytodyn Inc (CYDY)

[pearsby09]

Won’t be a niche product though. Will be a new SOC


I believe the combo trial, if approved, will start out in the market as a niche. I agree, if while on the market, the efficacy and safety aspects of PRO 140 continue to instill confidence in the physician adoption rate (many times reticence and "N" power in a new drug), then it may in time become SOC within the HAART regimen. All products take time to achieve peak market share. Look at Lipitor (statin) for dyslipidemia, it took 3 to 4 years to become a dominate player in that space..then became the number one selling drug in the world. My point is, IF approved for combo, starts as a niche and may in a year or two become SOC/HAART. IMO